The U.S. Food and Drug Administration (FDA) recently announced that it was taking pelvic mesh off the market after years of complaints and subsequent lawsuits by over 100,000 injured patients. These female victims claimed that mesh products caused painful complications. The response has left many scratching their heads as to why it has taken the FDA so long to take action after it first began studying the issue in 2011.
“These mesh devices were on the market for over 20 years, leaving tens of thousands of women to live with permanent disabilities and disfigurement. We feel the announcement, while a step in the right direction, also does not go far enough; it does not address other mesh devices that are causing similar life-altering injuries,” wrote Amanda Dykeman, the Illinois-based founder of Medical Device Problems.
Injuring those in need of help
The mesh was implanted to treat pelvic organ prolapse (POP), which occurs when tissues and muscles supporting the uterus, rectum and bladder become weak and allow the organs to drop and press against, fall into or fall out of the vagina. The mesh was supposed to support the organs and keep them in place but was found to cause severe pelvic pain, pain during intercourse, bleeding, organ perforation, infection, and urinary problems. POP affects about 3% of all women.
Settling without admitting guilt
Boston Scientific, Coloplast and other makers of these surgical products are quietly settling lawsuits while also trying to avoid admitting any fault, claiming they are safe and effective when used as directed. The companies are also trying to get the FDA to the approval of the mesh as safe for pelvic repair.
Getting the support you need
Women injured by these products can get the help they need from a personal injury attorney with experience handling medical malpractice. These legal professionals can help secure compensation for the traumatic pain and suffering caused by pelvic mesh as well as time away from work due to the complications it caused.